IBDEI0AZ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5179,2)
 ;;=^272609
 ;;^UTILITY(U,$J,358.3,5180,0)
 ;;=710.0^^41^482^76
 ;;^UTILITY(U,$J,358.3,5180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5180,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,5180,1,5,0)
 ;;=5^Syst Lupus Erythematosis
 ;;^UTILITY(U,$J,358.3,5180,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,5181,0)
 ;;=524.60^^41^482^77
 ;;^UTILITY(U,$J,358.3,5181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5181,1,4,0)
 ;;=4^524.60
 ;;^UTILITY(U,$J,358.3,5181,1,5,0)
 ;;=5^TMJ Syndrome
 ;;^UTILITY(U,$J,358.3,5181,2)
 ;;=^117722
 ;;^UTILITY(U,$J,358.3,5182,0)
 ;;=726.90^^41^482^78
 ;;^UTILITY(U,$J,358.3,5182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5182,1,4,0)
 ;;=4^726.90
 ;;^UTILITY(U,$J,358.3,5182,1,5,0)
 ;;=5^Tendonitis
 ;;^UTILITY(U,$J,358.3,5182,2)
 ;;=^41010
 ;;^UTILITY(U,$J,358.3,5183,0)
 ;;=354.2^^41^482^80
 ;;^UTILITY(U,$J,358.3,5183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5183,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,5183,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,5183,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,5184,0)
 ;;=715.97^^41^482^14
 ;;^UTILITY(U,$J,358.3,5184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5184,1,4,0)
 ;;=4^715.97
 ;;^UTILITY(U,$J,358.3,5184,1,5,0)
 ;;=5^DJD of Ankle/Foot
 ;;^UTILITY(U,$J,358.3,5184,2)
 ;;=DJD Ankle/Foot^272168
 ;;^UTILITY(U,$J,358.3,5185,0)
 ;;=731.0^^41^482^45
 ;;^UTILITY(U,$J,358.3,5185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5185,1,4,0)
 ;;=4^731.0
 ;;^UTILITY(U,$J,358.3,5185,1,5,0)
 ;;=5^Paget's Disease
 ;;^UTILITY(U,$J,358.3,5185,2)
 ;;=Paget's Disease^86892
 ;;^UTILITY(U,$J,358.3,5186,0)
 ;;=733.01^^41^482^44
 ;;^UTILITY(U,$J,358.3,5186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5186,1,4,0)
 ;;=4^733.01
 ;;^UTILITY(U,$J,358.3,5186,1,5,0)
 ;;=5^Osteoporosis, Senile
 ;;^UTILITY(U,$J,358.3,5186,2)
 ;;=Osteoporosis, Senile^87188
 ;;^UTILITY(U,$J,358.3,5187,0)
 ;;=733.02^^41^482^43
 ;;^UTILITY(U,$J,358.3,5187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5187,1,4,0)
 ;;=4^733.02
 ;;^UTILITY(U,$J,358.3,5187,1,5,0)
 ;;=5^Osteoporosis, Idiopathic
 ;;^UTILITY(U,$J,358.3,5187,2)
 ;;=Osteoporosis, Idiopathic^272692
 ;;^UTILITY(U,$J,358.3,5188,0)
 ;;=733.90^^41^482^41
 ;;^UTILITY(U,$J,358.3,5188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5188,1,4,0)
 ;;=4^733.90
 ;;^UTILITY(U,$J,358.3,5188,1,5,0)
 ;;=5^Osteopenia
 ;;^UTILITY(U,$J,358.3,5188,2)
 ;;=Osteopenia^35593
 ;;^UTILITY(U,$J,358.3,5189,0)
 ;;=733.13^^41^482^9
 ;;^UTILITY(U,$J,358.3,5189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5189,1,4,0)
 ;;=4^733.13
 ;;^UTILITY(U,$J,358.3,5189,1,5,0)
 ;;=5^Compression Fx of Spine
 ;;^UTILITY(U,$J,358.3,5189,2)
 ;;=Compression Fx of Spine^295754
 ;;^UTILITY(U,$J,358.3,5190,0)
 ;;=274.00^^41^482^30
 ;;^UTILITY(U,$J,358.3,5190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5190,1,4,0)
 ;;=4^274.00
 ;;^UTILITY(U,$J,358.3,5190,1,5,0)
 ;;=5^Gouty Arthritis NOS
 ;;^UTILITY(U,$J,358.3,5190,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,5191,0)
 ;;=274.01^^41^482^33
 ;;^UTILITY(U,$J,358.3,5191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5191,1,4,0)
 ;;=4^274.01
 ;;^UTILITY(U,$J,358.3,5191,1,5,0)
 ;;=5^Gouty Arthropathy, Acute
 ;;^UTILITY(U,$J,358.3,5191,2)
 ;;=^338226
 ;;^UTILITY(U,$J,358.3,5192,0)
 ;;=274.02^^41^482^31
 ;;^UTILITY(U,$J,358.3,5192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5192,1,4,0)
 ;;=4^274.02
 ;;^UTILITY(U,$J,358.3,5192,1,5,0)
 ;;=5^Gouty Arthritis, Chr
 ;;^UTILITY(U,$J,358.3,5192,2)
 ;;=^338227
 ;;^UTILITY(U,$J,358.3,5193,0)
 ;;=274.03^^41^482^32
 ;;^UTILITY(U,$J,358.3,5193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5193,1,4,0)
 ;;=4^274.03
